In general, ER-negative tumors are characterized by increased sTIL infiltration, CD8 + T-cells, and a higher expression of immune-related gene sets, resulting in a more inflamed tumor microenvironment, while ER-positive BC is traditionally considered to be an immunologically “cold” tumor [51,52]. Here, ESR1 is linked to neoplasm.